mercaptopurine has been researched along with Edema* in 15 studies
1 review(s) available for mercaptopurine and Edema
Article | Year |
---|---|
Periorbital Edema in a 7-year-old Girl.
Topics: Antigens, CD1; Biomarkers; Child; Diagnosis, Differential; Edema; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Mercaptopurine; Orbital Diseases; S100 Proteins; Tomography, X-Ray Computed | 2016 |
14 other study(ies) available for mercaptopurine and Edema
Article | Year |
---|---|
Oedema and Crohn's disease.
Topics: Adult; Amyloidosis; Crohn Disease; Edema; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Nephrotic Syndrome; Prednisolone; Serum Amyloid A Protein | 2010 |
Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation.
Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT), but membranous glomerulopathy (MG) has rarely been described as a manifestation of chronic GVHD. We report two cases of MG in children who underwent allogeneic HSCT. The clinical findings were characterized by edema of the lower extremities and nephrotic proteinuria in one case and hypertension, hematuria and edema with non-nephrotic proteinuria in the other one. Renal biopsy was consistent with MG and appropriate immunosuppressive therapy was prescribed. Both patients achieved complete remission and are alive without renal disease 4 and 2 years after the diagnosis of MG. The normal levels of albumin and non-nephrotic proteinuria in one of the two cases raise the question of whether the real incidence of MG after HSCT is underestimated. Therefore, we strongly suggest regular urine analysis during the follow-up of children undergoing HSCT in order to diagnose MG early. Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Edema; Glomerulonephritis, Membranous; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2005 |
Mechanisms underlying the suppression of adjuvant-induced arthritis by 6-mercaptopurine.
Daily oral administration of 6-mercaptopurine suppressed the development of the secondary (immune) lesions of adjuvant arthritis in a dose-related manner. The degrees of arthritis suppression corresponded closely to suppressions of concurrent development of the humoral and the cellular immune response to El4 cells. A short course of therapy during the sensitization period (day - 1 to day 5 when the day of adjuvant injection is designated as day 0) appeared to be almost as effective as continued daily dosing (day - 1 to day 15). The drug did not influence the development of the primary (nonimmune) lesions of adjuvant arthritis at all dosage levels investigated. Chronic pretreatment with 10 mg/kg/day PO for 17 days had no effect on the development of carrageenin-induced acute inflammation in the rat. The suppression of adjuvant arthritis by 6-mercaptopurine, unlike suppression by cyclophosphamide, appears to result primarily from its suppressive action on the immune response. Topics: Animals; Antibody Formation; Arthritis; Arthritis, Experimental; Carrageenan; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Edema; Immunity, Cellular; Mercaptopurine; Mice; Mice, Inbred Strains; Phenylbutazone; Rats; Time Factors | 1977 |
Some aspects of anti-inflammatory action of immunosuppressive drugs.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Azathioprine; Carrageenan; Connective Tissue; Connective Tissue Cells; Cyclophosphamide; Edema; Female; Hydrocortisone; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycobacterium; Rats; Time Factors | 1974 |
The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
Topics: Animals; Azathioprine; Busulfan; Carrageenan; Chlorambucil; Cyclophosphamide; Edema; Immunosuppressive Agents; Inflammation; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Rats; Time Factors | 1973 |
The influence of anti-inflammatory and immunosuppressant drugs on Nystatin induced oedema.
Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Arthritis; Aspirin; Azathioprine; Chloramphenicol; Cyclophosphamide; Dexamethasone; Drug Antagonism; Edema; Hydrocortisone; Immunosuppressive Agents; Indomethacin; Inflammation; Male; Mefenamic Acid; Mercaptopurine; Nystatin; Phenylacetates; Phenylbutazone; Prednisolone; Rats; Rifampin; Triamcinolone | 1971 |
Applications of the mouse foot edema test in evaluation of anti-cholera drugs.
Topics: Animals; Anti-Infective Agents; Aspirin; Chloramphenicol; Cholera; Cycloheximide; Dactinomycin; Diuretics; Edema; Emetine; Enterotoxins; Ethacrynic Acid; Fasting; Furosemide; Indomethacin; Iproniazid; Mercaptopurine; Mice; Models, Biological; Phenylbutazone; Protein Biosynthesis; Puromycin; Time Factors; Triamcinolone | 1971 |
[Cytostatic antiphlogistics. II. Antimicrobial activity range and comparison in the Oedipus test].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Aspirin; Azaguanine; Azathioprine; Bacteria; Benzimidazoles; Depression, Chemical; Edema; Enterococcus faecalis; Flufenamic Acid; Fungi; Indomethacin; Lactobacillus; Mefenamic Acid; Mercaptopurine; Oxyphenbutazone; Phenylbutazone; Purines; Pyrimethamine; Rats; Riboflavin; Salicylates; Staphylococcus; Tetracycline; Thioguanine | 1970 |
Mercaptopurine-dependent remission of nephrotic syndrome.
Topics: Adolescent; Edema; Humans; Hypoproteinemia; Male; Mercaptopurine; Nephrotic Syndrome; Time Factors | 1970 |
Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity.
Topics: Aminopyrine; Analgesics; Anaphylaxis; Animals; Anti-Inflammatory Agents; Aspirin; Bradykinin; Capillary Permeability; Carrageenan; Croton Oil; Depression, Chemical; Edema; Exudates and Transudates; Female; Guinea Pigs; Indomethacin; Inflammation; Male; Mefenamic Acid; Mercaptopurine; Mice; Phenylbutazone; Phenytoin; Pregnanes; Protein Denaturation; Rabbits; Radiation-Protective Agents; Rats; Sulfones; Yeast, Dried | 1970 |
Dermatomyositis.
Topics: Dermatomyositis; Edema; Female; Humans; Mercaptopurine; Middle Aged; Orbit; Prednisone | 1969 |
Effect of various nucleic acid and protein synthesis inhibitors on anaphylactoid inflammation in rats.
Topics: Anaphylaxis; Animals; Chloramphenicol; Dactinomycin; Dextrans; Edema; Emetine; Female; Ileum; Inflammation; Mannomustine; Mercaptopurine; Muscle Contraction; p-Methoxy-N-methylphenethylamine; Rats; Serotonin; Uterus | 1969 |
[Panel discussion. Edema. Edema in pediatrics].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Edema; Humans; Mercaptopurine; Nephrosis; Nephrotic Syndrome; Prednisolone; Prednisone | 1968 |
[TREATMENT OF LUPUS-NEPHROPATHIES WITH 6-MERCAPTOPURINE].
Topics: Albuminuria; Chloroquine; Diuretics; Edema; Glomerulonephritis; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Mercaptopurine; Nephritis; Nephrosis; Perinephritis; Prednisolone | 1964 |